HBIO vs NFLX · rev $22.7M vs P/E 25, rev $12.56B
Harvard Bioscience Inc (HBIO) versus Netflix Inc (NFLX) — a side-by-side from cached financials, not a winner call.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Netflix Inc (NFLX) is a entertainment company listed on NASDAQ.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
Latest reported NFLX revenue for 2026-06-30 was $12.56B. Net income was $3.40B. Revenue was up 2.5% from 2026-03-31 to 2026-06-30. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
HBIO currently screens at market cap $20.3M. NFLX currently screens at market cap $324.06B and trailing P/E 24.8.
Not investment advice. Open the HBIO and NFLX stock pages for the full models.
Not investment advice.